Canada - English - Health Canada

vpi pharmaceuticals inc - piperacillin (piperacillin sodium); tazobactam (tazobactam sodium) - powder for solution - 12g; 1.5g - piperacillin (piperacillin sodium) 12g; tazobactam (tazobactam sodium) 1.5g - extended-spectrum penicillins

Canada - English - Health Canada

vpi pharmaceuticals inc - piperacillin (piperacillin sodium); tazobactam (tazobactam sodium) - powder for solution - 36g; 4.5g - piperacillin (piperacillin sodium) 36g; tazobactam (tazobactam sodium) 4.5g - extended-spectrum penicillins

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - piperacillin sodium tazobactam sodium - pdr for soln for infusion - 2g/250 milligram

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - piperacillin sodium 4170 mg - eq. piperacillin 4000 mg; tazobactam sodium 536,6 mg - eq. tazobactam 500 mg - powder for solution for injection/infusion - 4 g - 0,5 g - piperacillin sodium 4170 mg; tazobactam sodium 536.6 mg - piperacillin and enzyme inhibitor

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - piperacillin sodium 2085 mg - eq. piperacillin 2000 mg; tazobactam sodium 268,3 mg - eq. tazobactam 250 mg - powder for solution for injection/infusion - 2 g - 0,25 g - piperacillin sodium 2085 mg; tazobactam sodium 268.3 mg - piperacillin and enzyme inhibitor

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - piperacillin sodium 2085 mg - eq. piperacillin 2000 mg; tazobactam sodium 268,3 mg - eq. tazobactam 250 mg - powder for solution for infusion - 2 g - 0,25 g - piperacillin sodium 2085 mg; tazobactam sodium 268.3 mg - piperacillin and enzyme inhibitor

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - piperacillin sodium 4170 mg - eq. piperacillin 4000 mg; tazobactam sodium 536,6 mg - eq. tazobactam 500 mg - powder for solution for infusion - 4 g - 0,5 g - piperacillin sodium 4170 mg; tazobactam sodium 536.6 mg - piperacillin and enzyme inhibitor

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eugia pharma (malta) ltd. - piperacillin sodium 2085 mg - eq. piperacillin 2000 mg; tazobactam sodium 268 mg - eq. tazobactam 250 mg - powder for solution for infusion - 2 g - 250 mg - piperacillin sodium 2085 mg; tazobactam sodium 268 mg - piperacillin and enzyme inhibitor

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eugia pharma (malta) ltd. - piperacillin sodium 4170 mg - eq. piperacillin 4000 mg; tazobactam sodium 536 mg - eq. tazobactam 500 mg - powder for solution for infusion - 4 g - 500 mg - piperacillin sodium 4170 mg; tazobactam sodium 536 mg - piperacillin and enzyme inhibitor

United States - English - NLM (National Library of Medicine)

wyeth piperacillin division of wyeth holdings corporation, a subsidiary of pfizer - tazobactam sodium (unii: uxa545abtt) (tazobactam - unii:se10g96m8w), piperacillin sodium (unii: m98t69q7hp) (piperacillin anhydrous - unii:9i628532gx) - tazobactam 4.5 g in 180 ml - zosyn (piperacillin and tazobactam for injection, usp) is indicated for the treatment of patients with moderate to severe infections caused by piperacillin-resistant, piperacillin/tazobactam-susceptible, β-lactamase producing strains of the designated microorganisms in the specified conditions listed below: appendicitis (complicated by rupture or abscess) and peritonitis caused by piperacillin-resistant, β‑lactamase producing strains of escherichia coli or the following members of the bacteroides fragilis group: b. fragilis , b. ovatus , b. thetaiotaomicron , or b. vulgatus . the individual members of this group were studied in less than 10 cases. uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses, and ischemic/diabetic foot infections caused by piperacillin-resistant, β‑lactamase producing strains of staphylococcus aureus . postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, β‑lactamase producing strains of escher